𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Silymarin for patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

✍ Scribed by Angulo, Paul; Patel, Tushar; Jorgensen, Roberta A.; Keach, Jill C.; Dickson, E. Rolland; Lindor, Keith D.

Book ID
122348535
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
171 KB
Volume
118
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Oral budesonide in the treatment of pati
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

Atorvastatin in patients with primary bi
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid
✍ Tatjana Stojakovic; Csilla Putz-Bankuti; GΓΌnter Fauler; Hubert Scharnagl; Martin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of